Our results also showed that the enhancement of invasion by BM plasma from patients with NDMM was neutralised by anti-TIMP1 antibody treatment, suggesting that TIMP1 stimulated fibroblast activity in the BM of patients with symptomatic MM. This evidence concerns the gene TIMP1 and Miyoshi myopathy.